Christopher Causey sold $1.3M of United Therapeutics (UTHR)

Executed Sep 2 2025, disclosed Sep 2 2025, the same day.

Value, as filed

$1.3M

3,000 sh across 3 lots

Executed

Sep 2 2025

the trade date, as filed

Disclosed

Sep 2 2025

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Christopher Causey Director profile →

Christopher Causey (Director) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in United Therapeutics Corporation (UTHR). The largest single filing was $786K of UTHR (1,300 sh × $604.64, as filed), executed Mar 30.

The name

UTHR

United Therapeutics Corporation UTHR · Healthcare · 343 filings in 24 months ticker →

Healthcare · United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Christopher Causey in UTHR

UTHRSALE United Therapeutics Corporation $786K
1,300 sh × $604.64
Exec Mar 30
Filed Mar 31 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $520K
1,000 sh × $520.00
Exec Feb 25
Filed Feb 25 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $510K
1,000 sh × $510.00
Exec Jan 6
Filed Jan 6 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $500K
1,000 sh × $500.01
Exec Jan 2
Filed Jan 5 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $440K
1,000 sh × $440.00
Exec Sep 24 2025
Filed Sep 25 2025 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $192K
510 sh × $376.63
Exec Nov 1 2024
Filed Nov 4 2024 · 5:30 PM ET